Home › NDC Lookup › RxCUI directory › RxCUI 209329

Nortriptyline 10 MG Oral Capsule [Pamelor] — RxCUI 209329

RxNorm drug concept · Semantic branded drug
RxCUI 209329 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI209329
Official nameNortriptyline 10 MG Oral Capsule [Pamelor]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPamelor 10 MG Oral Capsule; Pamelor (nortriptyline hydrochloride) 10 MG Oral Capsule
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)33 prescriptions · 1 state & territory Medicaid programs · latest period Q3 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nortriptyline: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is used to relieve symptoms of depression. It comes as capsules (including the brand Pamelor) and as an oral solution. The label notes that endogenous depressions are more likel...
  • You take it by mouth. Your prescriber will usually start you low and raise the dose slowly. It may be split through the day or taken once daily, so follow your label closely. Don't...
  • Dry mouth, blurred vision, constipation, trouble urinating, drowsiness and dizziness are among the common ones. Tell us if they bother you, since a dose change may help. Call your...
  • Yes. Antidepressants can increase suicidal thoughts in children, teens and young adults, especially early on. Watch for worsening mood or unusual behavior changes. If you notice an...
📖 Read our full Nortriptyline guide →

🕸️ Concept Web — How Nortriptyline 10 MG Oral Capsule [Pamelor] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nortriptyline 10 MG Oral Capsule [Pamelor] RxCUI 209329

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nortriptyline 7531
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pamelor 7866
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nortriptyline Oral Capsule 373124
    • Nortriptyline Oral Product 1159863
    • Nortriptyline Pill 1159864
    • Nortriptyline Oral Capsule [Pamelor] 366678
    • Pamelor Oral Product 1179438
    • Pamelor Pill 1179439
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nortriptyline 10 MG Oral Capsule SCD · 198045
  • Nortriptyline 10 MG SCDC · 328868
  • Nortriptyline Oral Capsule SCDF · 373124
  • Nortriptyline Oral Product SCDG · 1159863
  • Nortriptyline Pill SCDG · 1159864

Brand-Name Concepts

  • Nortriptyline 10 MG [Pamelor] SBDC · 569943
  • Nortriptyline Oral Capsule [Pamelor] SBDF · 366678
  • Pamelor Oral Product SBDG · 1179438
  • Pamelor Pill SBDG · 1179439
  • Pamelor BN · 7866

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 209329 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00406-9910-03 30 CAPSULE in 1 BOTTLE (0406-9910-03) PAMELOR SpecGx LLC 1977-08-01
00406-9911-03 30 CAPSULE in 1 BOTTLE (0406-9911-03) PAMELOR SpecGx LLC 1977-08-01
00406-9912-03 30 CAPSULE in 1 BOTTLE (0406-9912-03) PAMELOR SpecGx LLC 1977-08-01
00406-9913-03 30 CAPSULE in 1 BOTTLE (0406-9913-03) PAMELOR SpecGx LLC 1977-08-01
Observed labelers: SpecGx LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.